FDA Drug Application (077969) for IRBESARTAN AND HYDROCHLOROTHIAZIDE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number077969
Product Number001
FormTABLET;ORAL
Dosage12.5MG;150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameIRBESARTAN AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; IRBESARTAN

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient IRBESARTAN7


Back to FDA Applications sponsored by MYLAN PHARMS INC